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Background: Abdominal aortic aneurysms (AAA) primarily affect men over 65 years old who often have many
other diseases, with similar risk factors and pathobiological mechanisms to AAA. The aim of this study was to assess
the prevalence of simple renal cysts (SRC), chronic kidney disease (CKD), and other kidney diseases (e.g.
nephrolithiasis) among patients presenting with AAA.
Methods: Two groups of patients (97 AAA and 100 controls), with and without AAA, from the Surgical Clinic
Charité, Berlin, Germany, were selected for the study. The control group consisted of patients who were evaluated
for a kidney donation (n = 14) and patients who were evaluated for an early detection of a melanoma recurrence
(n = 86). The AAA and control groups were matched for age and sex. Medical records were analyzed and
computed tomography scans were reviewed for the presence of SRC and nephrolithiasis.
Results: SRC (74% vs. 57%; p<0.016) and CKD (30% vs. 8%; p<0.001) were both more common among AAA than
control group patients. On multivariate analysis, CKD, but not SRC, showed a strong association with AAA.
Conclusions: Knowledge about pathobiological mechanisms and association between CKD and AAA could provide
better diagnostic and therapeutic approaches for these patients.
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Abdominal aortic aneurysm (AAA) is the most common
type of aneurysm, and is defined as an abdominal aortic
diameter >3 cm [1]. According to recent literature, the
prevalence of AAA has decreased in the last decades and
is 1–2% [2]. This change can be primarily attributed to a
decreased prevalence of smoking [2, 3]. The prevalence
of AAA, however, increases with age and is 4.1%–14.2%
in men and 0.35 – 6.2% in women > 65 years [4, 5].© The Author(s). 2020 Open Access This artic
which permits use, sharing, adaptation, distrib
appropriate credit to the original author(s) and
changes were made. The images or other thir
licence, unless indicated otherwise in a credit
licence and your intended use is not permitte
permission directly from the copyright holder
The Creative Commons Public Domain Dedica
data made available in this article, unless othe
* Correspondence: irene.hinterseher@charite.de
†Milena Miszczuk and Verena Müller contributed equally to this work.
1Vascular Surgery Clinic, Klinik für Gefäßchirurgie, Campus Charité Benjamin
Franklin, Hindenburgdamm 30, 12200 Berlin, Germany
Full list of author information is available at the end of the articleAs AAA is asymptomatic in the majority of cases [6],
it is often initially detected as an incidental finding dur-
ing ultrasound or computed tomography (CT) examina-
tions. Unfortunately, many AAA cases remain
undetected until rupture. The mortality rate of a rup-
tured AAA is estimated to be 74–90% [7, 8], with a 32–
83% pre-hospital mortality rate [7, 9]. One way to reduce
this trend, is to implement a national AAA screening
program to detect AAA before rupture [10]. Such a pro-
gram was launched successfully in the USA in 2007 [11]
and in the Great Britain in 2009 [12].
A number of risk factors for AAA have been identi-
fied. The four primary risk factors are male sex, age > 65
years, smoking and a positive family history [13–18].le is licensed under a Creative Commons Attribution 4.0 International License,
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cluding chronic obstructive pulmonary disease (COPD)
[13, 19, 20], different types of hernia [20], gallstones
[21], and simple renal cysts (SRC) [22]. SRC is a com-
mon disease, with increased prevalence in older patients,
affecting 24–27% of those > 50 years of age [23, 24]. In
older individuals, SCRs are even more common; Carrim
et al. found an overall prevalence of 41% [25], while
Chang et al. reported a prevalence of 35% in >60-year
olds [26].
The co-occurrence of AAA and SRC [22, 27] can be
explained by shared risk factors, e.g. older age [26, 28,
29], male sex [25, 30], hypertension [31] and smoking
[26]. Ito et al. [22] stated “the presence of renal cysts
shows the strongest independent association with AAA
among patients belonging to the 65 to 74 years old group
and over 75 years old group”. The exact pathogenesis of
SRC remains unclear, but it is intriguing that both dis-
eases demonstrate increased matrix metalloproteinase
(MMP) levels, in the aortic wall in AAA patients [32]
and in the cystic fluid in patients with SRCs [33].
Given the potentially shared pathophysiology between
SRC and AAA, the primary aim of this study was to as-
sess the prevalence of SRC and other kidney diseases
among AAA patients, and compare the results to a
group of age- and sex-matched non-AAA patients from
the same hospital.Methods
The study was approved by the Charité Ethics Commit-
tee (approval number: EA1/309/16). Since the study was
a retrospective review of medical and imaging records,
no informed consent from the patients was required ac-
cording to the study approval.Study groups
This study was a retrospective review of patients’ med-
ical records including radiology records. Two groups of
patients were compared in the study. All 197 patients
had undergone a computed tomography-angiography
(CTA) scan. The first group (n=97) included patients,
who underwent AAA surgery in 2004 – 2012 at Charité
Clinic Campus Mitte in Berlin, Germany. Surgeries were
performed either as elective (unruptured AAA; n=92) or
as emergency (ruptured AAA; n= 5) operations. The ex-
clusion criteria were an abdominal aortic diameter <3
cm, AAA operation before 2004, diagnosis of rare gen-
etic disorder such as Marfan syndrome or Ehlers-Danlos
syndrome, and the presence of any other arterial
aneurysm. Further exclusion criterion was the presence
of genetic kidney diseases, such as autosomal dominant
polycystic kidney disease (ADPKD). For the AAA pa-
tients, the pre-operative scans were used.The control group (n=100) included patients without
AAA investigated at the Institute of Radiology of Charité
Clinic, Berlin, Germany, and consisted of patients who
were evaluated for a kidney donation in 2005 – 2014 (n
= 14) and patients who were evaluated for an early de-
tection of a melanoma recurrence (n = 86). We chose
this group of patients as a control group for the follow-
ing reasons: 1) they were also examined by abdominal
CTA; 2) melanoma is an age-related disease and a dis-
ease of a different organ, not the aorta; and 3) they were
from the same hospital system. Also, there were no dif-
ferences in the mean height, weight, or BMI between the
AAA and control groups [34].
AAA patients and controls were matched on sex and
age (± 2 years). For the AAA patients, age at the time of
the first AAA diagnosis was used for this analysis. If this
information was missing, age at the time of AAA surgery
was taken. For the control group, age during the CTA
scan was used for the analysis.
Clinical data
For the analysis of the CTA scans, Centricity eRadCock-
pit Software (GE Healthcare, Chalfont St Giles, Great
Britain) was used. First, written reports from board-
certified radiologists were reviewed by one of the au-
thors (M.M.). As SRCs are common, sometimes they
were not described as a diagnosis in the report. For that
reason, the CTA scans were assessed again for the pres-
ence of SRC (Fig 1) and kidney stones. Results were dis-
cussed with a board-certified radiologist (C.E.A.).
Individual data on all study patients for all vari-
ables used in the study are available in the Add-
itional file 1.
SRC (ICD-10: N28.1) were divided into subgroups ac-
cording to their size: Group 1: ≤1 cm; Group 2: 1.01 –
3.0 cm; Group 3: 3.1 – 5.0 cm; and Group 4: >5 cm.
SRCs were also classified using Bosniak Classification
System: I: simple, benign cysts; II: minimally complicated
benign cystic lesions; III: more complicated cystic le-
sions; and IV: cystic carcinoma [35].
Nephrolithiasis (ICD-10: N20.0) was defined as a pres-
ence of kidney stones on the CTA scans.
Additional patient data [34] were collected from
the medical records using the patient data manage-
ment program SAP (SAP SE, Walldorf, Germany).
Information about the presence of chronic kidney
disease (CKD) was collected. CKD was defined as a
presence of the following ICD-10 diagnostic codes in
the medical records: N18.1 for CKD stage 1, N18.2
for CKD stage 2, N18.3 for CKD stage 3, N18.4 for
CKD stage 4, N18.5 for CKD stage 5, and Z94.0 for
renal transplantation (Additional file 2). Additional
diseases in the same study groups are described in
another study [34].
Fig. 1 Simple renal cyst detected in a CT scan. Contrast-enhanced CT scan of the abdomen in axial (a) and coronal (b) plane, arterial phase,
demonstrates an AAA (arrowhead) with mural thrombus and patent lumen and a large hypodense mass on the lower left renal pole,
representing a simple renal cyst (arrow)
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For statistical analyses SPSS Statistics Version 22 for Win-
dows (IBM, Armonk, New York, USA) was used. First, a uni-
variable analysis was carried out. For quantitative variables,
the mean, median, standard deviation, minimal and maximal
values were determined. The categorical variables were ana-
lyzed using cross-tabulation. The differences between the
two groups were determined using Mann-Whitney U test or
chi-squared test (Fisher’s exact test) where appropriate. A dif-
ference was defined significant, if p≤0.05.
The univariable analysis was followed by a multivari-
able analysis to identify independent risk factors. Signifi-
cant values from the univariable analysis were included
in a multiple logistic regression model. This included
the following parameters: ever smoker, peripheral artery
disease (PAD), pack years of smoking, incisional hernia,
any hernia, congestive heart failure, American Society of
Anesthesiologists (ASA) score, diabetes mellitus, coron-
ary bypass, creatinine, COPD, current smoker, coronary
artery disease, diverticulosis, platelet count [34] and
SRC. Parameters with >50% of the values missing were
excluded from the analysis. A forward and backward
analysis was performed. Odds ratios (OR) and a 95%
confidence intervals (CI) were calculated. The analysis
was carried out on the entire study group as well as
stratified by age (< 65 and ≥ 65 years).
Results
Our study included 97 (76 male and 21 female) AAA pa-
tients and 100 (79 male and 21 female) age- and sex-
matched controls. Altogether, 29.9% AAA and 8% con-
trol patients had CKD diagnosis in their medical records
(p<0.001; Table 1). The distribution of CKD stages was
also statistically significantly different between the study
groups (p=0.002; Table 1). One AAA patient received a
renal transplantation due to the CKD. Nephrolithiasiswas found in 2.1% of the AAA and 7.1% of the control
patients (p=0.170). SRCs were found amongst 74.2%
AAA patients and 57% controls, resulting in a statisti-
cally significant difference (Table 1; p=0.016).
In the right kidney, SRCs were found in 59.8% of AAA
patients and in 46% of controls (p=0.064). In the AAA
group, 47.4% of patients had 1–4 SRCs, and 12.4% of pa-
tients had ≥5 SRCs. In the control group, these numbers
were 41% and 5%, respectively (p=0.05, for both compar-
isons; Table 1) . In the right kidney, SRCs ≤1 cm were
significantly more common among AAA than control
patients (p<0.001; Table 2).
In the left kidney, SRCs were found in 62.5% of AAA
and 33% of control patients (p<0.001; Table 1). In the
AAA group, 50% of patients had 1–4 SRCs, and 12.5%
of patients had ≥5 SRCs. In the control group, these
numbers were 29% and 4%, respectively (p<0.001, for
both variables; Table 1). In the left kidney, both small
(≤1 cm; p<0.001) and medium size (1 – 3 cm; p=0.020)
SRCs were significantly more common among AAA
than control patients (Table 3). In the AAA group, we
also found two patients with SRCs classified as Bosniak
II and two patients with SCRs classified as Bosniak III.
In the control group, one patient each with Bosniak II
and Bosniak III were found. There were 46 (47.4%) AAA
and 22 (22%) control group patients who had bilateral
SRC disease, whereas 25 (25.8%) AAA and 34 (34%)
control patients had SRCs in only the left or right kidney
(p=0.001).
In multivariable analyses we found a strong independent
association between AAA and CKD (OR = 5.528; 95%CI =
1.732–17.647; p=0.004). We found no direct association be-
tween SRC and AAA (OR = 1.693; 95%CI = 0.615–4.658;
p=0.308), when adjusting for other variables.
We also carried out the analyses separately for
those patients < and ≥ 65 years. In patients < 65
Table 1 Comparison of simple renal cysts and chronic kidney disease between study groups









CKD, all stagesb 29 97 8 100 <0.001
CKD stage 1/2/3/4/5/RTXc 5/9/11/1/2/1 97 1/4/3/0/0/0 100 0.002
Nephrolithiasis 2 97 7 98 0.170
SRC (both right and left kidney)d 72 97 57 100 0.016
SRC, right kidney only 58 97 46 100 0.064
1 – 4 SRC in right kidneyd 46 97 41 100 0.05
>5 SRC in right kidneyd 12 97 5 100 0.05
SRC, left kidney onlyd 60 97 33 100 <0.001
1 – 4 SRC in left kidneyd 48 97 29 100 <0.001
> 5 SRC in left kidneyd 12 97 4 100 <0.001
aChi-square test
bDefined as presence of ICD-10 code in medical records: N18.1 for CKD stage 1, N18.2 for CKD stage 2, N18.3 for CKD stage 3, N18.4 for CKD stage 4, N18.5 for
CKD stage 5 or Z94.0 for renal transplantation.
cDefined as presence of kidney stones (ICD-10: N20.0) on the CTA scans.
dDefined as presence of simple renal cysts (ICD-10: Q61.9) on the CTA scans.
CKD Chronic kidney disease; SRC Simple renal cyst; RTX Renal transplantation.
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only parameter with a statistically higher prevalence
in the AAA group (p = 0.001; Table 4). In patients ≥
65 years (68 AAA and 79 control patients), AAA pa-
tients suffered significantly more often from CKD (p
= 0.002), SRC (p = 0.018) and SRC on left kidney
only (p = < 0.001; Table 5). Further, CKD showed an
independent association with AAA in multivariate
analysis in this older age group (OR = 6.503; 95%CI
= 2.088 – 20.255; p = 0.001).
Discussion
The main findings of our study were that CKD was
more frequent in AAA than age- and sex-matched con-
trol patients and showed a strong association with AAA
in multivariable analysis, which included ever smoker,
PAD, pack years, incisional hernia, any hernia, congest-
ive heart failure, ASA score, diabetes mellitus, coronary





Number of SRC per
patient
Mean+/-SD





≤1 cm 1.15 ± 1.86 0 97
1.1 cm – 3.0
cm
0.43 ± 0.95 0 97
3.1 cm – 5.0
cm
0.10 ± 0.34 0 97
>5 cm 0.02 ± 0.14 0 97
aMann-Whitney U test
SRC Simple renal cystartery disease, diverticulosis, platelet count and SRC.
AAA patients also had a higher rate of SRC, but SRCs
were not independently associated with AAA.
Our study demonstrated a strong association between
AAA and CKD with 29.9% of the AAA and only 8% of
the age- and sex-matched control patients diagnosed
with CKD. The AAA patients also exhibited a more ad-
vanced CKD stage. Previously published studies reported
a wide range of CKD prevalence (3–65%) among AAA
patients [20, 36–39]. Alnassar et al. [36] and Pitoulias
et al. [20] found no significant difference in the preva-
lence of CKD between AAA and PAD patients [20, 36].
However, patients with a large AAA (>5.5 cm) had a sig-
nificantly higher rate of CKD than patients with a small
AAA (13% vs. 2%) [20]. Approximately half (52.6%) of
the AAA patients in our study had a large AAA (>5.5
cm) and all were operated on for AAA, and the rate of
CKD was over four times as high as the rate in the study
of Pitoulias et al [20]. Furthermore, similar to thetheir size
Control group pa
Number of SRC per
patient
Mean+/-SD





0.50 ± 1.45 0 100 <0.001
0.41 ± 0.79 0 100 0.99
0.05 ± 0.26 0 100 0.15
0.04 ± 0.20 0 100 0.68





Number of SRC per
patient
Mean+/-SD





Number of SRC per
patient
Mean+/-SD





≤1 cm 1.28 ± 2.08 1 96 0.37 ±1.17 0 100 <0.001
1.1 cm – 3.0
cm
0.56 ± 0.95 0 96 0.30 ± 0.73 0 100 0.02
3.1 cm – 5.0
cm
0.10 ± 0.31 0 96 0.04 ± 0.20 0 100 0.10
>5 cm 0.01 ± 0.10 0 96 0.00 ± 0.00 0 100 0.49
aMann-Whitney U test
SRC Simple renal cyst
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study demonstrated an independent association of AAA
and CKD in multivariable analysis, not seen in the study
by Pitoulias et al. [20].
We estimated the prevalence of SRC to be 74.2% in
the AAA and 57% in the control group. Based on
previous literature, the SRC prevalence in general
population varies 4.2–41% [25, 28], which is lower
than in the current study (Table 6). Similarly, the
SRC prevalence among AAA patients in the current
study was higher than in most of the previous studies,
which reported a prevalence of 38–69% among AAA
patients and 19–45% for controls [20, 22, 27, 40–42].
A recent study by Brownstein et al. [42] analyzed a
total of 35,498 patients who underwent both chest
and abdominal CT imaging during a 4-year period.
Altogether 18% of these patients had SRC and 2.6%
had AAA. Compared with the matched population
without SRC, patients with SRC demonstrated an in-
creased prevalence of AAA (8% vs. 3%). They were
also more likely to have thoracic, ascending and de-
scending aortic aneurysms or dissections [42]. Five
previous studies found an independent association be-
tween AAA and SRC in a multivariable analysis [20,
22, 27, 40, 42], but we could not confirm this in our
study. However, three of those studies [22, 40, 42] ex-
amined a significantly larger patient group.Table 4 Univariate analysis of AAA in patients < 65 years old
Variable AAA
Age (mean ± SD), years 58.7 ±
AAA diameter at first diagnosis (mean ± SD), mm 54.3 ±
AAA diameter at surgery (mean ± SD), mm 62.1 ±
Male 93.1%
Chronic kidney disease 27.6%
Simple renal cysts 58.6%
Simple renal cysts right kidney 51.7%
Simple renal cysts left kidney 39.3%
Group size not large enough to perform a multivariate analysis.Ito et al. [22] found an association between AAA and
SRC in their multivariable analysis, but only in patients
> 65 years. Because of low patient numbers, we were not
able to analyze the patients < 65 years separately. Our
analyses with the older patients (≥ 65 years) showed a
significantly higher prevalence of CKD in the AAA
group (31% vs. 10%) with an independent association in
the multivariate analysis (OR = 6.5, p = 0.001). Also,
SRC were significantly more frequent in the AAA group
(81% vs. 62%, p = 0.018), however, we were not able to
confirm an independent association in the multivariate
analysis. Therefore, our analysis partially confirm the re-
sults previously published by Ito et al. [22]. Age is also
an important risk factor for SRC. Prior studies have con-
firmed that SRC develops mostly at older age [24, 25, 28,
29, 40, 41], and Ito et al. [22] and Yaghoubian et al. [27]
found a significant difference in the age of patients with
and without SRC in the general population.
SRC and AAA share some common risk factors,
e.g. older age, male sex and hypertension [25, 26,
28–31], and some studies also mention smoking as a
possible risk factor for SRC [26]. Molecular studies
suggest that MMPs play a role in the pathophysi-
ology of SRC and AAA [33]. Furthermore, one study
on 108 autopsies showed a correlation between the
diameter of the abdominal aorta and the number of
SRC [43].(n = 29) Controls (n = 21) p








Table 5 Univariate and multivariate analysis of AAA in patients >65 years old
Variable Univariate analysis Multivariate analysis
AAA (n = 68) Controls (n = 79) p OR 95%CI p
Age (mean ± SD), years 73.3 ± 5.8 74.5 ± 6.1 0.169 - - -
AAA diameter at first diagnosis (mean ± SD), mm 50.9 ± 13.0 - - - - -
AAA diameter at surgery (mean ± SD), mm 57.6 ± 10.1 - - - - -
Male 72.1% 77.2% 0.568 - - -
CKD 30.9% 10.1% 0.002 6.503 2.088 – 20.255 0.001
SRC 80.9% 62.0% 0.018 2.5 0.736 – 8.497 0.142
SRC right kidney 63.2% 50.6% 0.136 - - -
SRC left kidney 72.1% 35.4% < 0.001 - - -
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only of academic, but also of clinical interest. Nowadays,
the majority of AAA are repaired using endovascular
aneurysm repair (EVAR), which requires a contrast
agent administration, known to be nephrotoxic. Only
one study has investigated the kidney function in pa-
tients with SRC after EVAR [41], and found that patients
with SRC had slightly higher creatinine levels, both be-
fore and after surgery, but the difference was not statisti-
cally significant [41]. There was no significant difference
in the creatinine levels after EVAR [41], leading to the
conclusion that kidney function is not affected by the
presence of SRC. As we have reported previously, in the
current study population, the AAA group patients had
significantly higher creatinine levels than the control
group patients [34].
Nephrolithiasis is a common problem in the elderly
population. A higher prevalence of nephrolithiasis has
been reported in patients with SRC [26] and ADPKD
[44]. The relationship between renal stones and AAA
has not been investigated previously. As SRC appear fre-
quently in AAA patients [22, 27, 45], one might expect
that nephrolithiasis affects AAA patients as well. In our
study population, we found no association between AAA
and nephrolithiasis. Nonetheless, when examining a pa-
tient with a renal colic, one should consider a symptom-
atic or ruptured AAA as a potential differential
diagnosis.
The association between AAA and CKD also requires
further research by examining the role CKD plays on the
development and progression of AAA. It has been re-
ported that blood vessel walls in patients with CKD are
thinner, which can increase the risk for rupture [46].
The co-occurrence of AAA and CKD also has several
clinical implications, since CKD increases the rate of
complications after surgery [47]. The clot inside the
aneurysm sac can also impair the blood perfusion of
renal arteries (e.g. by embolization).
Further, CKD patients are known to suffer from vita-
min D deficiency [48]. Wong et al. [49] reported thatvitamin D deficiency may be a potential risk factor for
AAA, but the association was weak with OR = 1.23
(95%CI = 0.87-1.73). Thus, the literature on the associ-
ation between AAA and vitamin D levels is still sparse
and additional studies are required.
The main limitation of our study is the fact that this
was a retrospective single-center study with a small
number of patients and controls. Another possible limi-
tation is the fact that the control group consisted of pa-
tients with melanoma and those evaluated for kidney
donation and their comorbidity profile might not be rep-
resentative of the general population. Especially patients
with melanoma may have had a stronger sun exposure
and therefore could have higher vitamin D levels which
are potentially associated with AAA and CKD. However,
a comparison of our two control groups (kidney dona-
tion vs. melanoma) showed no difference in the preva-
lence of CKD or SRC between these two groups (both p
> 0.05, not shown). Therefore, we assume that the po-
tential bias caused by the vitamin D levels in melanoma
patients is of minimal importance.
Our study evaluated patients with larger AAAs which
were treated surgically. This might have caused a selec-
tion bias and the results might not be representative of
all AAA patients. A major advantage of our study was
matching of patients and controls on sex and age min-
imizing the confounding effects attributed to these
factors.
Conclusions
A better understanding about the pathophysiology of
AAA will facilitate the development of pharmacother-
apies for AAA. Also, this knowledge could be used for a
better risk stratification. By introducing a national
screening program in every country, AAA could be de-
tected earlier. It is also important to consider the pos-
sible complications arising from CKD, both after open
aneurysm repair, and EVAR. This group of patients
should be given special attention and risk factor analysis
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search is also needed on patients with small AAA who
develop problems in kidney function. It remains to be
determined if renal function is also affected by an expan-
sion and different types of AAA where the renal arteries
are involved.
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